|
|
Glaucoma
We are one of four labs that are part of a collaborative project, Catalyst for a Cure that is dedicated to understanding the mechanisms by which retinal ganglion cells die in glaucoma as well as identifying potential therapeutic interventions. The other laboratories involved in the CFC collaborative are those of Monica Vetter (U. Utah), Phil Horner (U. Washington), and David Calkins (Vanderbilt U.). Most of these studies involve a mouse model of glaucoma, the DBA/2J mouse. |
